Record Revenue Achieved in 1H19 Primarily Due to Increased Demand for Vascepa Guidance for Total 2019 Revenue Increased to a Range of $380 to $420 Million from $350 Million Following Unaudited Second Quarter Results Estimated Between $97 and $101 Million, or Between $170 and $174 Million for the First Half […]
Other News
Highlander Partners Announces the Acquisition of Ares, the Leading Private Interventional Cardiology Provider in Romania
BUCHAREST, Romania, July 2, 2019 /PRNewswire/ — Highlander Partners L.P., a leading middle market private investment firm based in Dallas, Texas, today announced the acquisition of the majority stake in the Ares Group (“Ares”). Founded in 2013 and headquartered in Bucharest, Ares is the leading private provider of interventional cardiology procedures in Romania, with 5 facilities […]
TransPerfect Reaffirms Commitment To Pediatric Cardiology With Third Annual Gift To Babies Heart Fund
NEW YORK, July 1, 2019 /PRNewswire/ — TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced its third consecutive year of donating to the Babies Heart Fund (BHF) to advance the treatment of congenital heart disease through innovative research and patient care. All BHF donations go to […]
With Innovative Health’s landmark clearance to reprocess the leading electrophysiology mapping catheter from Biosense Webster, single-use device reprocessing has entered a new era.
SCOTTSDALE, Ariz., June 28, 2019 /PRNewswire-PRWeb/ — Innovative Health, the leading single-use cardiology medical device reprocessing company, today announced it has received FDA clearance for reprocessing the market-leading PENTARAY® Nav eco High-Density mapping catheter (hereinafter PentaRay), a development that represents both a technological and healthcare cost reduction milestone. The PentaRay is a key […]
CorWave to Report First Successful In Vivo Survival at 30-Day Milestone with Its Innovative LVAD Cardiac Support Device
CLICHY, France–(BUSINESS WIRE)–CorWave announced today that results from chronic preclinical studies to evaluate its Left Ventricular Assist Device (LVAD) will be presented at the 65th Annual Conference of the American Society for Artificial Internal Organs (ASAIO) in San Francisco. The poster presentation, entitled “Low Shear, High Flow, and Physiologic Pulsatility: […]
Quanterix Announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year® 2019 Award Winner in New England
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Kevin Hrusovsky, Chairman and CEO of Quanterix, and Founder of Powering Precision Health (PPH), has been recognized with the Entrepreneur Of The Year® 2019 Award in the New […]
BIOTRONIK Launches Next Generation Injectable Cardiac Monitor in the CE Region
BERLIN–(BUSINESS WIRE)–BIOTRONIK today announced the market release of its new injectable cardiac monitor (ICM), BIOMONITOR III, following approval in the CE region. The novel device is designed to help patients with irregular heart rhythms by documenting suspected arrhythmia or unexplained syncope with increased clarity. As the most common type of arrhythmia, 33.5 […]
Eko Unveils Algorithm to Assist in the Detection of Aortic Stenosis, a Valvular Heart Disease Affecting Over 3 Million People in the U.S.
Berkeley, June 28, 2019 (GLOBE NEWSWIRE) — Eko, a Berkeley-based digital health company applying artificial intelligence and machine learning in the fight against heart disease, unveiled an investigational Aortic Stenosis (AS) detection algorithm at the American Society of Echocardiography (ASE) 2019 Scientific Sessions aimed to assist healthcare providers in the early detection of […]
Novoheart Holdings Inc. Completes Acquisition of Xellera Therapeutics
VANCOUVER, British Columbia, June 29, 2019 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) is pleased to announce that it has completed its previously announced acquisition (the “Acquisition”) of all of the shares of Xellera Therapeutics Limited (“XT”). As consideration for the Acquisition, Novoheart has issued […]
BioSig Technologies, Inc. Added to Membership of Russell 3000® Index
Santa Monica, CA, July 01, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ:BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that it has been added as a member of the broad-market Russell 3000® Index, […]



